ACE CancerPlus

Increasingly, oncologists and pathologists are utilizing information on genomic alterations in solid tumors, such as lung, colon, breast, skin, and prostate cancers, to help guide and optimize therapeutic options for patients. The Personalis ACE CancerPlus Test provides clinicians a comprehensive and accurate next generation sequencing based testing solution for solid tumors.